At Celligenics, we are reinventing the way forward by harnessing regenerative technology to support the body in repairing, regenerating, and restoring itself to a state of well-being. Established in 2016, Celligenics is a spin-off of the Agency for Science, Technology & Research (A*STAR), Singapore’s leading public R&D agency, and one of A*STAR’s top 10 new biotech start-ups in 2018. We are also a finalist for Singapore’s Emerging Enterprise Award 2021, the top business award jointly organised by OCBC Bank and The Business times that recognises the ambitions of emerging enterprises. Celligenics Announces China Market Entry, & Signs MOU With West China Hospital. Celligenics, NTU, & SRIS Collaborate On New Therapy For Chronic Wounds (Sep 2021). Our regenerative extract is a platform technology, with limitless application potential. Two product lines are currently under development, with more to come. Traditional skincare products lose their effectiveness over time, and stronger and more expensive products are then required to maintain the health of our skin.
San Jose, Philippines
Founded in 2016
11-50 Employees
Working industry
Biotechnology
Type of company
-
Ownership structure
Privately Held
Locations
1 Headquarter
Specialised areas
Biotechnology
An estimation about the ESG values based on digital data and signals. Important: The ESG scores are only based on information about the country, not the actual company itself
Country:
Philippines
Overall risk estimation:
High
The ESG Data of countries are based on public sources
Environment
D
Grade (A-E)
View details
Social
C
Grade (A-E)
View details
Governance
D
Grade (A-E)
View details
Celligenics operates in 1 country around the world
Get an overview of the locations of Celligenics
Location
Country
State
City
Headquarter
Philippines
Nueva Ecija
San Jose
Some frequent questions that have been asked about Celligenics
Where is Celligenics located?
The company headquarter of Celligenics is located in San Jose, Nueva Ecija, Philippines. It's worth noting, that the company may have more locations
How many employees does Celligenics approximately have?
As of the latest available information Celligenics has around 11-50 employees worldwide.
When was Celligenics founded?
Celligenics was founded in 2016
In which industries does Celligenics mainly work?
The company Celligenics has it's main focus in the industries of Biotechnology
Check out some interesting alternative companies to Celligenics
CellResearch Corporation
San Jose, Philippines
1-10 Employees
2002
CellResearch Corporation was founded in Singapore in 2002 by scientists with a keen interest and expertise in Cell Biology. It’s original remit was to provide skin and scar cells to laboratories around the world for research, as well as to perform contract research for skin research laboratories internationally. Do not compromise on your future with unlicensed techniques or banking providers. CALECIM® Cosmeceuticals Pte Ltd is a skin care company based on CALECIM®.
BioGenCell
Netanya, Israel
1-10 Employees
2008
Our mission is to make personalized cell therapy a reality for patients worldwide, providing accessible treatments to various unmet needs. Meet the people behind BioGenCell: A Group of Dedicated BioMed, Healthcare, Vascular and Business Professionals, Including a Nobel Prize Laureate and World-Renowned Scientists. BioGenCell is dedicated to changing the lives of patients suffering from degenerative microvascular diseases, stopping disease progression, reversing disability, reducing pain, and enhancing functionality. BioGenCell’s groundbreaking cell-therapy treatments aim to provide more accessible, reliable and cost-effective therapeutic options, with the hope of significantly impacting these tragic figures. BioGenCell’s Phase 2 Clinical Trial assesses the safety and efficacy of the BGC101 cell therapy in treating Chronic Limb-Threatening Ischemia. Since its inception in 2008, BioGenCell has been committed to transforming the lives of patients with degenerative diseases through advanced cell therapy treatments, based on the Company’s groundbreaking TRACT technology that uses a patient’s own blood as personalized medicine. Our innovative TRACT technology allows for stem cell therapies that are patient-friendly and physician-friendly. Through advanced, standardized procedures, we are dedicated to bringing transformative cell therapy treatments to vascular physicians and surgeons, podiatrists, and various other healthcare providers and clinicians.
Re-gen Active Lab
Irving, United States
11-50 Employees
2018
All our products are developed in our own cutting edge ISO Class 3 laboratory facility by highly trained scientists and engineers. We are proud to have developed stem cell-derived products from a minimally manipulated eligible human umbilical cord and placenta tissue without a combination of any other articles that raise new clinical safety concerns with respect to our products. Our products contain stem cell-derived bio-active biomolecules, cell fragments, cell contents, and its extracellular matrix. This makes our products stand out in the market for two main reasons. First, our products contain stem cells derived bioactive biomolecules that act as a signals to initiate tissue regeneration within minutes of administration, and second, we are fully compliant with Section 361 of the PHS Act and FDA 21CFR 1271 by not including an intact live cell in our products but all the components of it. We are here to help, and our products may assist your body to repair itself. Re-gen Active Lab is an Irving, Texas, based Biotechnology Company established in 2018 with a goal of revolutionizing regenerative medicine through the development of novel stem cell therapy for wound healing, regeneration, anti-inflammatory, and well-being applications. We have total control over all the steps involved in our product development process to achieve high levels of safety, purity, potency, viability, and reproducibility (batch to batch consistency).
StemGenn Therapeutics
India
11-50 Employees
2014
StemGenn is dedicated to advancing the field of regenerative medicine & Molecular Medicine by offering the highest quality technology, cellular therapy and training. StemGenn is committed to maintaining its leading position within the infertility sector of the cell technology industry by delivering stem cell therapies and biologics that help address Poor ovarian reserve, Asherman syndrome, Thin Endometrium, Erectile dysfunction, SUI , menopause management and other issues. StemGenn goals are to improve a patient’s quality of life by regenerating their damaged tissue, when possible, and by reducing health care costs and hospitalisations. StemGenn leading procedure , Lipokraft, O-Cell PRP is a clinical adipose cell therapy & concentrated plasma designed to populate regions of scar tissue within a patient’s with new living cells for the purpose of improving function in degenerative conditions. We are an international med tech company that is focused in the field of stem cell & regenerative medicine. We are devoted to developing therapeutic products & services that have the potential to be safer and are more effective than the current standard of care. Our products and services are aimed at providing better treatment and management for the diseases leading to a better quality of life. StemGenn Therapeutics is a Biotechnology Company promoting disruptive regenerative medicines.
CELLnLIFE
Kazan, Russia
- Employees
2018
CELLnLIFE Inc. is a company that develops immune disease treatments using IntenCell®, an efficacy-enhancing stem cell. Based on the independently developed S-I-S culture platform technology, we are striving to overcome therapeutic efficiency limitations of stem cell therapy, thereby delivering healthy life and wellness to suffering patients with unmet medical needs. We are constantly challenging ourselves and do our best to grow into a company that can lead the global stem cell therapy market, while maintaining strong corporate ethics. 8th floor 50, Digital-ro 33-gil, Guro-gu, Seoul, Republic of Korea.
S-Cell Health
Los Angeles, United States
1-10 Employees
-
S-CELL Health & Beauty uses cutting edge technology and the latest scientific breakthroughs to support the body's ability to rejuvenate a particular health concerns. S-CELL Health & Beauty, a brand of VitaCell International Co. Located in Hong Kong, S-CELL Health & Beauty's inspiration to provide the best of both worlds remains strong. S-CELL Health & Beauty aims to bring the finest in wellness through the fusion of the newest developments in cellular health and the use of natural and top-of-the-line ingredients for the purpose of enriching the quality of living, as exemplified by its first products that included NAD+ cellular boosters, Cell Revival and NAD Revival, which were the first to be sold in Asia and are now ready to be introduced to the rest of the world. S-CELL Health & Beauty is committed to provide products that are derived from natural ingredients and are proven safe and effective by scientific knowledge. Since the beginning of S-CELL Health & Beauty in 2016, the company has been riding the wave of human clinical results releases which have reinforced the breakthrough discovery of Dr. All ingredients used in S-CELL Health & Beauty's formulations are subjects of numerous clinical studies that have been recognized as the best nutraceutical ingredients by the industry authorities for the proven benefits to healthy aging. All of S-CELL Health & Beauty's products, which are manufactured in the United States and in the United Kingdom, have passed the stringent requirements of both the US Food and Drug Administration (FDA) and the British Retail Consortium (BRC) of the United Kingdom.